Passage Bio Inc. (NASDAQ: PASG)
$0.5310
-0.0050 ( -1.67% ) 70.9K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.5310
Previous close
$0.5360
Volume
70.9K
Market cap
$32.89M
Day range
$0.5230 - $0.5700
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 8-k | 8K-related | 13 | May 22, 2024 |
| 8-k | 8K-related | 47 | May 14, 2024 |
| 10-q | Quarterly Reports | 63 | May 14, 2024 |
| def | Proxies and info statements | 4 | Apr 09, 2024 |
| ars | Annual reports | 1 | Apr 09, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |